CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Phase II Trial of Weekly 24-Hour Infusion of Gemcitabine in Patients with Advanced Gallbladder and Biliary Tract Carcinoma
DOI 10.1055/s-2005-920174
Bibliografische Angaben
Nachweis in CareLit
Autor:innenS von Delius, C Lersch, E Schulte-Frohlinde, M Mayr, RM Schmid, F Eckel
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe04/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: Patients with advanced gallbladder and biliary tract carcinoma face a dismal prognosis, as no effective palliative chemotherapy exists. The antitumor effect of gemcitabine is schedule-dependent rather than dose-dependent. We evaluated the activity of a prolonged infusion of gemcitabine in advanced gallbladder and biliary tract carcinomas. Methods: Nineteen consecutive eligible patients were enrolled. All patie…
Zitieren
Zitierempfehlung
S von Delius, C Lersch, E Schulte-Frohlinde, M Mayr, RM Schmid, F Eckel (2006) Phase II Trial of Weekly 24-Hour Infusion of Gemcitabine in Patients with Advanced Gallbladder and Biliary Tract Carcinoma. Zeitschrift für Gastroenterologie (04). https://doi.org/10.1055/s-2005-920174
Mit CareLit weiterarbeiten